Skip to main content
    O

    Opko Health Inc (OPK)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $1.61
    +0.24 (+17.52%)

    Market Cap: $1.02B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    67%(26/39)
    Avg Surprise
    -5.76%
    Streak
    9 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-0.07
    Range$-0.08 - $-0.06
    2 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$-0.11+36.4%
    60d ago$-0.11+36.4%
    30d ago$-0.11+36.4%
    7d ago$-0.070.0%
    Current$-0.07
    Revenue Consensus
    $137M
    Range$135M - $138M
    6 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.03
    Range$0.03 - $0.03
    1 analysts
    Revenue Consensus
    $171M
    Range$168M - $174M
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.03---
    Sep 26EST
    		-$-0.07---
    Jun 26
    Reported Jul 27
    		$-0.01N/A+87.50%Beat+87.5%
    Mar 26
    Reported Apr 28
    		$-0.07$-0.07+0.00%Beat+22.2%
    Dec 25
    Reported Feb 26
    		$-0.04$-0.07+42.86%Beat-500.0%
    Sep 25
    Reported Oct 29
    		$0.03$-0.04+175.00%Beat+0.0%
    Jun 25
    Reported Jul 31
    		$-0.08$-0.10+20.00%Beat-700.0%
    Mar 25
    Reported Apr 30
    		$-0.09$-0.11+18.18%Beat+25.0%
    Dec 24
    Reported Feb 27
    		$0.01N/A+110.00%Beat+111.1%
    Sep 24
    Reported Nov 7
    		$0.03N/A+133.33%Beat+127.3%
    Jun 24
    Reported Aug 7
    		$-0.01N/A+88.89%Beat+66.7%
    Mar 24
    Reported May 7
    		$-0.12$-0.09-33.33%Miss-500.0%
    Dec 23
    Reported Feb 27
    		$-0.09$-0.09+0.00%Beat+18.2%
    Sep 23
    Reported Nov 6
    		$-0.11$-0.10-10.00%Miss+0.0%
    Jun 23
    Reported Aug 3
    		$-0.03N/A+57.14%Beat+78.6%
    Mar 23
    Reported May 3
    		$-0.02N/A+75.00%Beat+75.0%
    Dec 22
    Reported Feb 23
    		$-0.11$-0.11+0.00%Beat+0.0%
    Sep 22
    Reported Nov 8
    		$-0.11$-0.08-37.50%Miss-375.0%
    Jun 22
    Reported Aug 4
    		$-0.14$0.03-566.67%Miss-366.7%
    Mar 22
    Reported May 9
    		$-0.08$-0.06-33.33%Miss-260.0%
    Dec 21
    Reported Feb 24
    		$-0.11$-0.02-450.00%Miss-320.0%
    Sep 21
    Reported Oct 28
    		$0.04$-0.01+500.00%Beat+0.0%
    Jun 21
    Reported Jul 29
    		$-0.03$0.02-250.00%Miss-160.0%
    Mar 21
    Reported Apr 28
    		$0.05$0.05+0.00%Beat+155.6%
    Dec 20
    Reported Feb 18
    		$0.05$0.04+25.00%Beat+127.8%
    Sep 20
    Reported Oct 29
    		$0.04$0.04+0.00%Beat+136.4%
    Jun 20
    Reported Jul 30
    		$0.05$-0.07+171.43%Beat+145.5%
    Mar 20
    Reported May 6
    		$-0.09$-0.09+0.00%Beat+30.8%
    Dec 19
    Reported Feb 26
    		$-0.18$-0.09-100.00%Miss-100.0%
    Sep 19
    Reported Nov 5
    		$-0.11$-0.09-22.22%Miss-120.0%
    Jun 19
    Reported Aug 7
    		$-0.11$-0.11+0.00%Beat-266.7%
    Mar 19
    Reported May 7
    		$-0.13$-0.11-18.18%Miss-62.5%
    Dec 18
    Reported Feb 27
    		$-0.09$-0.09+0.00%Beat+71.9%
    Sep 18
    Reported Nov 9
    		$-0.05$-0.06+16.67%Beat+37.5%
    Jun 18
    Reported Aug 7
    		$-0.03N/A+57.14%Beat+0.0%
    Mar 18
    Reported May 8
    		$-0.08$-0.13+38.46%Beat-33.3%
    Dec 17
    Reported Mar 1
    		$-0.32$-0.08-300.00%Miss-1500.0%
    Sep 17
    Reported Nov 8
    		$-0.08$-0.05-60.00%Miss-
    Jun 17
    Reported Aug 8
    		$-0.03$-0.05+40.00%Beat-
    Mar 17
    Reported May 9
    		$-0.06$-0.04-50.00%Miss-
    Dec 16
    Reported Mar 1
    		$-0.02$-0.04+50.00%Beat-

    Key Metrics

    Valuation
    P/E Ratio-17.89EV/EBITDAN/A
    Price/FCF-9.07xFCF Yield-11.02%
    Profitability
    Profit Margin-12.40%Operating Margin-15.30%
    ROE-5.88%ROIC-2.86%
    Financial Health
    Debt/Equity0.29xInterest Coverage0.60x
    Current Ratio3.35xQuick Ratio2.93x
    Trading Statistics
    Beta1.50Avg Volume4.53M
    52-Week High$1.7552-Week Low$0.98

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.44
    SMA 20$1.55
    SMA 50$1.51
    SMA 200$1.33
    EMA 10$1.46
    EMA 20$1.50
    EMA 50$1.49
    EMA 200$1.39

    MACD

    Line: -0.03Signal: -0.02Hist: -0.01

    ADX

    ADX: 32.2+DI: 39.5-DI: 23.6

    Aroon & PSAR

    Aroon Up32.0
    Aroon Down96.0
    PSAR$1.30

    Bollinger Bands

    Upper Band$1.81
    Lower Band$1.28
    %B Position3428%(Upper)
    Band Width0.62

    RSI (14-Day)

    Neutral
    58.2

    Momentum Oscillators

    Stoch %K32.3
    Stoch %D16.2
    Williams %R-22.5
    ROC (10d)2.5%
    Momentum0.04
    CCI (20d)29.7
    MFI (14d)76.5

    Volatility Measures

    ATR (14d)$0.08(5.1%)
    StdDev (20d)0.13
    Hist Vol77.7%(High)

    Volume Flow

    VWAP$1.60
    OBV36.8M
    AD Line-36.2M
    CMF (20d)0.090

    Volume Metrics

    Avg Vol (20d)4.8M
    Vol Ratio11.6x(High)
    VWMA (20d)$1.59

    Pivot Points

    R3$1.46
    R2$1.42
    R1$1.39
    Pivot Point$1.35
    S1$1.32
    S2$1.28
    S3$1.25

    Advanced Oscillators

    TSI-13.52
    Ultimate Osc51.5
    KST-52.80

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$163.58M$124.20M$148.45M$151.67M$156.81M$149.95M$183.64M$173.63M$182.19M$173.69M$181.91M$178.59M
    Cost of Revenue$83.56M$78.44M$84.43M$101.78M$107.41M$107.33M$98.98M$133.50M$130.53M$131.62M$137.20M$130.92M
    Gross Profit$80.02M$45.76M$64.03M$49.89M$49.40M$42.62M$84.66M$40.13M$51.65M$42.07M$44.71M$47.68M
    Operating Expenses$86.99M$96.77M$102.34M$1.84M$109.38M$109.79M$117.80M$25.91M$113.32M$113.54M$113.75M$112.08M
    R&D$33.17M$29.20M$32.77M$30.08M$30.34M$30.84M$30.43M$28.77M$24.08M$21.94M$19.39M$19.43M
    SG&A$52.92M$48.61M$50.52M$53.80M$59.60M$59.09M$67.03M$98.20M$68.82M$70.17M$72.88M$72.24M
    Operating Income$-6,972,000$-51,017,000$-38,316,000$48.06M$-59,981,000$-67,168,000$-33,139,000$14.22M$-61,670,000$-71,472,000$-69,045,000$-64,407,000
    Interest Income$3.22M$3.01M$3.82M$3.02M$3.29M$4.68M$4.29M$2.93M$391,000$813,000$906,000$970,000
    Interest Expense$11.38M$10.94M$11.31M$11.36M$70.33M$15.47M$14.24M$17.36M$8.18M$7.69M$3.45M$3.38M
    Income Before Tax$-13,399,000$-60,956,000$-46,901,000$41.43M$-162,520,000$-73,374,000$34.98M$48.42M$-10,584,000$-83,183,000$-72,494,000$-78,378,000
    Income Tax Expense$-4,983,000$-6,110,000$-15,661,000$19.80M$-14,079,000$-5,770,000$20.95M$23.53M$-280,000$-1,350,000$-6,019,000$6.08M
    Net Income$-8,416,000$-54,848,000$-31,257,000$21.63M$-148,441,000$-67,613,000$14.03M$24.89M$-10,305,000$-81,836,000$-66,483,000$-84,473,000
    EBITDA$17.31M$-30,686,000$-16,900,000$72.64M$-67,924,000$-38,672,000$69.62M$87.40M$21.79M$-49,971,000$-43,650,000$-49,332,000
    EBIT$-5,240,000$-53,024,000$-39,410,000$49.77M$-95,480,000$-62,589,000$44.93M$62.85M$-2,795,000$-76,310,000$-69,946,000$-75,964,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OPK

    Government Contracts

    Gov Obligations (TTM)
    -$180092
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Opko Health stock hits 52-week high at 1.75 USD

    Opko Health's stock reached a new 52-week high of $1.75 USD, trading at $1.76 USD with a market capitalization of $1.29 billion. This surge follows a 17% gain over the past week and a 33% increase over six months...

    Investing.com•10/16/26•Bullish

    OPKO Health (NASDAQ:OPK) Stock Rating Raised to Outperform at Barrington Research

    Barrington Research has upgraded OPKO Health (NASDAQ:OPK) from "market perform" to "outperform," setting a $2.25 price target...

    MarketBeat•10/16/26•Bullish

    OPKO Health (NASDAQ:OPK) Shares Gap Up - What's Next?

    OPKO Health (NASDAQ:OPK) shares gapped up significantly, opening at $1.65 after closing at $1.37, with heavy trading volume. Despite exceeding quarterly expectations with a loss of $0.01 per share and increased revenue...

    MarketBeat•10/15/26•Somewhat-Bullish

    Labcorp to Acquire Certain Assets of OPKO Health's BioReference Health Subsidiary for $722 Million

    Labcorp has announced an agreement to acquire certain assets from OPKO Health's BioReference Health subsidiary for $722 million. The article indicates this is a premium news item from MT Newswires...

    Yahoo Finance•10/15/26•Bullish

    OPK Stock Grinds Lower As Traders Focus On Cash And Charts

    Opko Health Inc. (OPK) stock has been slipping despite strong gross margins and a significant cash reserve, indicating persistent selling pressure. While premarket volatility offers short-term trading opportunities...

    www.timothysykes.com•10/15/26•Somewhat-Bearish

    OPK Valuation and Fair Value

    P/E
    -17.9x
    Forward P/E
    53.8x
    P/FCF
    -9.1x
    PEG
    93.7x
    P/B
    1.0x
    See GNG's fair value

    OPK Profitability: Margins, ROIC and FCF

    Gross margin
    40.8%
    Operating margin
    -15.3%
    Net margin
    -12.4%
    ROIC
    -2.9%
    ROE
    -5.9%
    FCF margin
    -22.8%
    FCF yield
    -11.0%

    OPK Competitors

    CompanyTicker
    Integra LifeSciences HoldingsIART
    Harrow Health IncHROW
    HealthStream IncHSTM
    Castle Biosciences IncCSTL
    Artivion IncAORT
    Ventyx Biosciences IncVTYX
    CureVac NVCVAC
    Savara IncSVRA

    Sector: Healthcare

    OPK Analyst Ratings

    Consensus
    Buy
    Analysts
    6
    Strong Buy
    2
    Buy
    2
    Hold
    2
    Sell
    0
    Strong Sell
    0

    OPK Bull Case vs Bear Case

    Bull case

    • OPK beat EPS estimates in 87.5% of its last 8 reported quarters.
    • 66.7% of OPK's analyst ratings are Buy or Strong Buy.

    Bear case

    • OPK has a -12.4% net profit margin.

    OPK Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    73.4%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-0.07
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    1 up, 0 down

    Frequently Asked Questions About OPK

    Does OPK pay dividends?

    Opko Health Inc (OPK) does not currently pay a regular dividend.

    What is OPK's market cap?

    Opko Health Inc (OPK) has a market capitalization of $1.02B with a current stock price of $1.61.

    Related stocks

    Sector: Healthcare

    All stocks starting with O

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In